| アブストラクト | BACKGROUND: The inappropriate use of antibiotics is understood to contribute to antimicrobial resistance. Oral antibiotics are regularly used to treat moderate-to-severe acne vulgaris. In practice, we do not know the typical length of oral antibiotic treatment courses for acne in routine primary care and what proportion of people receive more than one course of treatment following a new acne diagnosis. OBJECTIVES: To describe how oral antibiotics are prescribed for acne over time in UK primary care. METHODS: We conducted a descriptive longitudinal drug utilization study using routinely collected primary care data from the Clinical Practice Research Datalink GOLD (2004-2019). We included individuals (8-50 years) with a new acne diagnosis recorded between 1 January 2004 and 31 July 2019. RESULTS: We identified 217 410 people with a new acne diagnosis. The median age was 17 years [interquartile range (IQR) 15-25] and median follow-up was 4.3 years (IQR 1.9-7.6). Among people with a new acne diagnosis, 96 703 (44.5%) received 248 560 prescriptions for long-term oral antibiotics during a median follow-up of 5.3 years (IQR 2.8-8.5). The median number of continuous courses of antibiotic therapy (>/= 28 days) per person was four (IQR 2-6). The majority (n = 59 010, 61.0%) of first oral antibiotic prescriptions in those with a recorded acne diagnosis were between the ages of 12 and 18. Most (n = 71 544, 74.0%) first courses for oral antibiotics were for between 28 and 90 days. The median duration of the first course of treatment was 56 days (IQR 50-93 days) and 18 127 (18.7%) of prescriptions of >/= 28 days were for < 6 weeks. Among people who received a first course of oral antibiotic for >/= 28 days, 56 261 (58.2%) received a second course after a treatment gap of >/= 28 days. The median time between first and second courses was 135 days (IQR 67-302). The cumulative duration of exposure to oral antibiotics during follow-up was 255 days (8.5 months). CONCLUSIONS: Further work is needed to understand the consequences of using antibiotics for shorter periods than recommended. Suboptimal treatment duration may result in reduced clinical effectiveness or repeated exposures, potentially contributing to antimicrobial resistance. |
|---|
| ジャーナル名 | The British journal of dermatology |
|---|
| Pubmed追加日 | 2023/1/22 |
|---|
| 投稿者 | Bhate, Ketaki; Mansfield, Kathryn E; Sinnott, Sarah-Jo; Margolis, David J; Adesanya, Elizabeth; Francis, Nick; Leyrat, Clemence; Hopkins, Susan; Stabler, Richard; Shallcross, Laura; Langan, Sinead M; Mathur, Rohini |
|---|
| 組織名 | Faculty of Epidemiology and Population Health, London School of Hygiene and;Tropical Medicine, London, UK.;Department of Dermatology and Department of Biostatistics and Epidemiology,;University of Pennsylvania, Philadelphia, PA, USA.;School of Primary Care, Population Sciences and Medical Education, University of;Southampton, Southampton, UK.;UK Health Security Agency, London, UK.;Faculty of Infectious and Tropical Diseases, London School of Hygiene and;Faculty of Population Health Sciences, University College London, London, UK. |
|---|
| Pubmed リンク | https://www.ncbi.nlm.nih.gov/pubmed/36670540/ |
|---|
